BRIEF-Fate Therapeutics Says Bob Valamehr To Become President, CEO As Of Jan 2025

Reuters11-30

BRIEF-Fate <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Says Bob Valamehr To Become President, CEO As Of Jan 2025

Nov 29 (Reuters) - Fate Therapeutics Inc FATE.O:

FATE THERAPEUTICS ANNOUNCES LEADERSHIP TRANSITION
FATE THERAPEUTICS INC - SCOTT WOLCHKO TO RETIRE AS PRESIDENT AND CEO DEC 31, 2024
FATE THERAPEUTICS INC - BOB VALAMEHR TO BECOME PRESIDENT AND CEO JAN 1, 2025
FATE THERAPEUTICS INC - SCOTT WOLCHKO TO CONTINUE AS STRATEGIC ADVISOR

Source text: ID:nGNXYWfDk

Further company coverage: FATE.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2487938205?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-30 02:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2487938205","market":"us","top_or_hot":-1,"title":"BRIEF-Fate Therapeutics Says Bob Valamehr To Become President, CEO As Of Jan 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Fate <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Says Bob Valamehr To Become President, CEO As Of Jan 2025</title></head><body><p><span>Nov 29 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/FATE\">Fate Therapeutics Inc</a> <span>FATE.O</span>:</p><ul><li><p>FATE THERAPEUTICS ANNOUNCES LEADERSHIP TRANSITION</p></li><li><p>FATE THERAPEUTICS INC - SCOTT WOLCHKO TO RETIRE AS PRESIDENT AND CEO DEC 31, 2024</p></li><li><p>FATE THERAPEUTICS INC - BOB VALAMEHR TO BECOME PRESIDENT AND CEO JAN 1, 2025</p></li><li><p>FATE THERAPEUTICS INC - SCOTT WOLCHKO TO CONTINUE AS STRATEGIC ADVISOR</p></li></ul><p>Source text: <span>ID:nGNXYWfDk</span></p><p>Further company coverage: <span>FATE.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Fate Therapeutics Says Bob Valamehr To Become President, CEO As Of Jan 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Fate Therapeutics Says Bob Valamehr To Become President, CEO As Of Jan 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-30 02:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241129:nTUA4CHXDY:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Fate Therapeutics Says Bob Valamehr To Become President, CEO As Of Jan 2025Nov 29 (Reuters) - Fate Therapeutics Inc FATE.O:FATE THERAPEUTICS ANNOUNCES LEADERSHIP TRANSITIONFATE THERAPEUTICS INC ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241129:nTUA4CHXDY:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241129:nTUA4CHXDY:1","article_id":"2487938205","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2487938205","pubTimestamp":1732904204,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Fate Therapeutics Says Bob Valamehr To Become President, CEO As Of Jan 2025Nov 29 (Reuters) - Fate Therapeutics Inc FATE.O:FATE THERAPEUTICS ANNOUNCES LEADERSHIP TRANSITIONFATE THERAPEUTICS INC ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","FATE":"Fate Therapeutics Inc"},"translate_title":"BRIEF-Fate Therapeutics表示Bob Valamehr将于2025年1月起担任总裁兼首席执行官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FATE":0.9},"content_text":"BRIEF-Fate Therapeutics Says Bob Valamehr To Become President, CEO As Of Jan 2025Nov 29 (Reuters) - Fate Therapeutics Inc FATE.O:FATE THERAPEUTICS ANNOUNCES LEADERSHIP TRANSITIONFATE THERAPEUTICS INC - SCOTT WOLCHKO TO RETIRE AS PRESIDENT AND CEO DEC 31, 2024FATE THERAPEUTICS INC - BOB VALAMEHR TO BECOME PRESIDENT AND CEO JAN 1, 2025FATE THERAPEUTICS INC - SCOTT WOLCHKO TO CONTINUE AS STRATEGIC ADVISORSource text: ID:nGNXYWfDkFurther company coverage: FATE.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2487938205"}